Study found a link between heart condition and Covid

According to a study there is a link between heart condition and Covid. Researchers at Cedars-Smidt Sinai’s Cardiac Institute found that there is a connection between a debilitating heart condition and Covid-19, as well as a new link between the same condition and the Covid-19 vaccine.



According to The Tribune, “Their findings, published in the peer-reviewed journal Nature Cardiovascular Research, suggest that a small percentage of patients vaccinated against Covid-19 may develop postural orthostatic tachycardia syndrome, or POTS. The investigators also found that those diagnosed with Covid-19 are five times more likely to develop the same cardiac condition after infection than after vaccination, emphasizing the importance of the vaccine.”

“The main message here is that while we see a potential link between Covid-19 vaccination and POTS, preventing Covid-19 through vaccination is still the best way to reduce your risk of developing POTS,” said Alan C. Kwan, MD, first and corresponding author of the study and a cardiovascular specialist at Cedars-Sinai.

The Tribune also said, “Postural orthostatic tachycardia syndrome is a nervous system-related condition that most commonly affects young women of childbearing age. The most identifiable POTS symptom is a rapid increase in the heartbeat of more than 30 beats per minute, or a heart rate that exceeds 120 beats per minute, within 10 minutes of standing. Other symptoms include fainting, dizziness and fatigue, although some patients with severe disease may also experience migraine, increased urination, sweaty extremities, anxiety, and tremor.”

“From this analysis, we found that the odds of developing POTS are higher 90 days after vaccine exposure than the 90 days prior to exposure,” said Kwan. “We also found that the relative odds of POTS were higher than would be explained by increases in visits to physicians after vaccination or infection.” Kwan emphasizes that despite this finding, the rates of POTS after vaccination were much lower than rates of new POTS diagnosis after Covid-19.

For more updates on pharma and life science, Click here